ENDOCUR - Modulation of Endotoxaemia Via Curcumin Intake in Healthy Overweight Adults
Launched by UNIVERSITY OF GLASGOW · Oct 30, 2017
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - BMI \> 25 kg/m2.
- Exclusion Criteria:
- • having chronic inflammatory or autoimmune disease, gastrointestinal complaints or known biliary obstruction (past and present)
- • use of anti-inflammatory drugs 2 weeks before the start of the study
- • use of antibiotics during the 12 weeks preceding the trial
- • pregnancy
- • lactation
About University Of Glasgow
The University of Glasgow is a prestigious academic institution renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of medicine and health sciences to design and conduct innovative clinical trials. With a strong focus on ethical standards and patient safety, the University of Glasgow collaborates with multidisciplinary teams and partners to translate research findings into practical applications, fostering advancements in medical knowledge and therapeutic interventions. Its dedication to excellence in research and education positions the university as a leader in clinical trial initiatives that aim to address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials